Table 1

Updates of the guidelines, and consensus on the recommendation of active surveillance management for low risk papillary thyroid microcarcinomas after active surveillance outcomes from Kuma Hospital were published in 2014

AffiliationPublication yearStatement typeActive surveillanceImmediate surgeryReference
BTA2014Guideline24
ATA2015Guideline10
Netherlands2015Guideline25
CATO2016Consensus26
UK national multidisciplinary2016Guideline27
KTA2016Guideline28
NHCC2018Guideline29
Italian2018Consensus30
Polish§2018Guideline31
JAES2018Guideline32
ESMO2019Guideline33
SEOM2019Guideline34
NCCN2019Guideline11
African2019Guideline35
AAES2020Guideline36

CATO, Chinese Association of Thyroid Oncology; ATA, American Thyroid Association; AAES, American Association of Endocrine Surgeons; BTA, British Thyroid Association; ESMO, European Society for Medical Oncology; JAES, Japan Associations of Endocrine Surgeons; KTA, Korean Thyroid Association; NCCN, National Comprehensive Cancer Network; NHCC, National Health Commission of China; SEOM, Spanish Society for Medical Oncology. ○ Not Recommended; ● recommended; ◑ selective under strict conditions. For search strategies, see Supplement 1. Joint statements of six Italian societies: the Italian Thyroid Association, the Medical Endocrinology Association, the Italian Society of Endocrinology, the Italian Association of Nuclear Medicine and Molecular Imaging, the Italian Society of Unified Endocrine Surgery and the Italian Society of Anatomic Pathology and Diagnostic Cytology. §Joint statements of Polish national societies: the Polish Endocrine Society, Polish Society of Oncology, Polish Thyroid Association, Polish Society of Pathologists, Society of Polish Surgeons, Polish Society of Surgical Oncology, Polish Society of Clinical Oncology, Polish Society of Radiation Oncology, Polish Society of Nuclear Medicine, Polish Society of Pediatric Endocrinology, Polish Society of Pediatric Surgeons, Polish Society of Ultrasonography.